Hydroxyurea
on
29.8.08
with
0 comments
You are here: Home » Pharmacology Notes » Hydroxyurea
mechanism of action: ribonucleotide reductase (RNR) inhibitor, so it’s S-phase specific and nonmutagenic
toxicity: myelosuppression
uses: myeloproliferative diseases (polycythemia vera, essential thrombocythemia); sickle-cell anemia
Category: Pharmacology Notes
POST COMMENT
0 comments:
Post a Comment